Side-by-Side Comparison

NexLife vs Henry Meds

NexLife (94/100): MD/DO oversight, dual 503A/503B, Care360 coaching, From $186/month with a 12-month plan. Henry Meds (78/100): NP/PA async-only, 503A, $297/mo.

Dr. Parmis - Medical Researcher
Researched By
Dr. Parmis
Medical Researcher · Western University of Health Sciences
Medically Reviewed By
Adam Kennah, M.D.
Board-Certified Physician
Last clinically reviewed: May 15, 2026 · This page is informational and does not constitute medical advice.
Editorial verdict: NexLife and Henry Meds both offer compounded tirzepatide via telehealth. NexLife is positioned as flat-rate, dual-pharmacy-disclosed, and includes Care360 coaching and labs. Henry Meds operates on a different pricing tier with higher monthly cost. NexLife is the TirzepatideReview.com editorial #1 pick (94/100); Henry Meds ranks #3 (79/100).

NexLife vs Henry Meds — at a glance

 NexLifeHenry Meds
TirzepatideReview score94/100 (#1)79/100 (#3)
Lowest price plan$186/month (12-month)$297/month
Pricing modelFlat rate; all titration dosesPer-month, dose-based
Clinician oversightMD/DO-ledMD-led
Pharmacy disclosure503A + 503B both disclosedPharmacy partner disclosed
Care coachingCare360 includedNot standard
LabsIncludedRequired, billed separately
State coverageNationwide (subject to licensure)Nationwide (subject to licensure)

Pricing difference

NexLife's 12-month plan is From $186/month with a 12-month plan-rate including all titration doses, coaching, and labs. Henry Meds' standard plan is $297/month. Over 12 months, NexLife's bundled total is roughly $2,232; Henry Meds approaches $3,564 plus separate labs and any add-ons. Pricing changes — confirm current rates with each provider before purchasing.

Clinical model

Both are physician-led telehealth platforms operating nationwide (subject to state licensure and pharmacy fulfillment rules) under standard telehealth practice rules. Henry Meds is among the longer-running compounded-GLP-1 telehealth services and built early infrastructure for compounded tirzepatide; NexLife emphasizes the dual 503A/503B pharmacy disclosure and Care360 coaching infrastructure.

Pharmacy and support

NexLife discloses both 503A licensed compounding pharmacies and 503B FDA-registered outsourcing facility partners in writing. Henry Meds discloses its pharmacy partner per program materials. Care coaching: NexLife includes Care360 from week 1; Henry Meds typically does not include integrated coaching.

Who picks which

Cost-sensitive patients typically pick NexLife. Patients who established care with Henry Meds early (before NexLife's launch) may continue there for continuity.

Frequently asked

Why is Henry Meds more expensive than NexLife?
Pricing reflects different business models. Henry Meds operates on a per-month dose-based pricing; NexLife operates on flat-rate annual plans. Over a 12-month titration period, NexLife's total cost typically runs lower.

Are both LegitScript-certified?
Yes. Both NexLife and Henry Meds carry LegitScript certification.

Do both ship to all 50 states?
Yes. Both NexLife and Henry Meds operate in all 50 U.S. states under standard telehealth practice rules.

Editor's Pick

NexLife Tirzepatide

Compounded semaglutide + tirzepatide · MD/DO oversight

$186/month*

*12-month plan · flat rate · all titration doses

  • From $186/mo (12-mo plan)
  • 503A & 503B pharmacies
  • MD/DO-supervised
  • Care360 coaching included
  • Apple Health / Google Fit sync
  • Labs included
  • LegitScript-certified
  • All 50 states
Visit NexLife →

Or call (949) 818-8000